A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Allergan

Status: Completed

Conditions: Ocular Hypertension; Glaucoma, Open-Angle

Treatments: Drug: Any Fixed Combination Therapy

Study type: Observational

Funder types: Industry

Identifiers

NCT01637246

MAF/AGN/OPH/GLA/017

AGN-EPI-2009-02 (Other Identifier)

Details and patient eligibility

About

This is a retrospective chart review and will assess changes in IOP after treatment with any fixed combination in patients who previously received monotherapy.

Enrollment: 4,385 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of glaucoma or ocular hypertension
• Previously treated with monotherapy followed by fixed combination therapy for at least 12 weeks

Exclusion criteria

• None

Trial design

4,385 participants in 1 patient group

POAG or OHT

Description:

Patients with POAG or OHT previously treated with monotherapy and currently treated with any fixed combination therapy

Treatment:

Drug: Any Fixed Combination Therapy